Eton Pharmaceuticals (ETON) Change in Receivables (2020 - 2025)
Eton Pharmaceuticals (ETON) posted Change in Receivables of -$1.3 million for Q4 2025, up 3.36% sequentially from -$1.4 million in Q3 2025, and down 241.11% YoY from $939000.0 in Q4 2024.
Eton Pharmaceuticals (ETON) Change in Receivables (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Change in Receivables for 6 years, with the latest figure at -$1.3 million in Q4 2025.
- Quarterly Change in Receivables fell 241.11% year-over-year to -$1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (up 105.13% YoY) and the FY2025 annual result came in at $6.4 million, up 105.13% from the prior year.
- Change in Receivables rose to -$1.3 million in Q4 2025 per ETON's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Change in Receivables peaked at $11.0 million in Q1 2025 and troughed at -$4.7 million in Q1 2022.
- A 5-year average of $643850.0 and a median of $303000.0 in 2021 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2021 and 2022: Change in Receivables soared 10495.83% in 2021, then slumped 1955.16% in 2022.
- Over 5 years, Change in Receivables stood at $5.1 million in 2021, then plunged by 93.04% to $354000.0 in 2022, then tumbled by 123.73% to -$84000.0 in 2023, then surged by 1217.86% to $939000.0 in 2024, then slumped by 241.11% to -$1.3 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$1.3 million, -$1.4 million, and -$1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.64 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | 11.04 Mn |
| Mar 31, 2025 | 11.04 Mn |
| Dec 31, 2024 | 939,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 717,000.00 |
| Sep 30, 2024 | 717,000.00 |
| Jun 30, 2024 | 633,000.00 |
| Jun 30, 2024 | 633,000.00 |
| Mar 31, 2024 | 829,000.00 |
| Mar 31, 2024 | 829,000.00 |
| Dec 31, 2023 | -84,000.00 |
| Dec 31, 2023 | -84,000.00 |
| Sep 30, 2023 | 411,000.00 |
| Sep 30, 2023 | 411,000.00 |